IL1B and systemic-onset juvenile idiopathic arthritis: Furthermore, TNF-α immunomodulators have previously been used as a common treatment for RA and IL-1β immunomodulators are effective with other chronic diseases such as systemic-onset juvenile idiopathic arthritis and in adult onset Still's diseases [29], [31].